New AD Derm drug

Quote




anonymous said:
Let’s be clear, we are not being paid on Rx’s.
Now this could go two ways or both.

Short game -
We are TBO only this year and a little compensation for Eucrisa. We don’t know what this class is going to produce in AD. It’s not fair to set a goal for a drug and a class that is a shot in the dark with with the ammo being a tough label, no access and not knowing what hoops insurance companies are going to make the HCP and patient go through to get it. This actually makes sense and is favor of the reps. Once we know what the potential is, they set goals the next year.

Long game -
Now I called this a year ago. This could be the “get comfortable” phase of the navigator rep model. We are not being compensated on Rxs anymore and will go completely to a TBO model. When Lotz started rambling on one of those calls early last year and spilled the beans that was an indication. He tried to clean up the mess before he bailed that I&I was gonna be goal oriented sales force but too little too late. Pfizer has wanted this for years. Why?
1. The amount of $ we have spent on off label promotion the last 20 years (usually through acquisitions of other companies) is as much as a year of vax sales. Insane.
2. We are now completely tied to the Fed govt with the vax. We will do whatever it takes to avoid damaging the relationship. They are our #1 customer and will continue to be as healthcare evolves.
3. Public opinion is at stake. The last thing Pfizer wants is bad press. We had an email last month that touted how wonderful everyone thinks we are. Why do you think they kept us home for 14 months? The last thing Pfizer wanted was bad press of reps spreading Covid and shutting down offices while making a vaccine for Covid.

If they lump the target bonus in our salaries I’m fine with it. Unless you are #1, you never see your target bonus anyway. And if it’s in your salary it’s not taxed at the highest rate. It’s actually a pay increase. Not sure how it will effect the career progression, etc.

My guess is that this is their goal in the long run.
Click to expand...

This is the exact playbook from T1 release. There’s no mystery here.
 












The warnings are a class warning based on Xeljanz. May see these adverse events, but most likely not if choose the right pt. They use methotrexate and accutane which read like a poison recipe so there that. No clue on salary, etc. Depends on the algorithm we use and your experience.
 




We don't get numbers on Cibinqo. Eucrisa zero pressure as sales plummet. TBO's are awesome if you're able to play the game. This is the easiest job in pharma. Vaccine will support us with their sales, we make a couple calls a day, enter a few we didnt make, the managers that are here know the game and are playing with us. Ride this out as long you can, get your severance and move on. Most other companies are not tuned in to what we're doing here so I wouldn't worry to much with other companies knowing we're not performance driven or care about pay for performance.
 








anonymous said:
The warnings are a class warning based on Xeljanz. May see these adverse events, but most likely not if choose the right pt. They use methotrexate and accutane which read like a poison recipe so there that. No clue on salary, etc. Depends on the algorithm we use and your experience.
Click to expand...


Thanks for the info.

I was on Eucrisa, and it burned and didn't work at all. I don't know of one person who has had any success with Eucrisa. I wonder if anyone is using it at all? The Derm I go to never uses it, and he says it's worthless and also burns.
 




It works. Actually pretty well. But it’s a maintenance med. 1st sign of flare is itch. Apply then and you likely won’t flare. Prob is patients wait til they are on fire before making an appointment. Then you have a mid level derm who doesn’t educate the patient. So the cycle continues.
 








anonymous said:
It works. Actually pretty well. But it’s a maintenance med. 1st sign of flare is itch. Apply then and you likely won’t flare. Prob is patients wait til they are on fire before making an appointment. Then you have a mid level derm who doesn’t educate the patient. So the cycle continues.
Click to expand...


I tried it and it did nothing. I don't know of one Derm who likes it, and most say it's a total bust.

I'd love to find a topical that actually works. Dupixent didn't do much for me either, but I'm concerned about the warnings on this product. There is so much coverup with all Pharma that I don't even believe the percentages. I wonder if I'll have to live with this forever. Dupixent caused me lots of eye problems and they so underreport it.
 




anonymous said:
It works. Actually pretty well. But it’s a maintenance med. 1st sign of flare is itch. Apply then and you likely won’t flare. Prob is patients wait til they are on fire before making an appointment. Then you have a mid level derm who doesn’t educate the patient. So the cycle continues.
Click to expand...

No this Eucrisa was awful. It burned no matter when I put it on. I don't know of any dermatologist who likes it. I'd like to try your product, but I'm concerned about all of the warnings. I don't trust any of the data as the Dupixent pi shows so few eye problems, and it causes a lot of eye issues--makes eyes itch even worse and I couldn't tolerate it
 




anonymous said:
It works. Actually pretty well. But it’s a maintenance med. 1st sign of flare is itch. Apply then and you likely won’t flare. Prob is patients wait til they are on fire before making an appointment. Then you have a mid level derm who doesn’t educate the patient. So the cycle continues.
Click to expand...

this is off label. Eucrisa wasn’t studied like this and you can’t back this up with data. Don’t blame a mid-level for not educating patients, because if you promoted like this in front of a Pfizer attorney you’d be fired.
Also, that turd of a product would still sting and burn.
 




Guess we won’t have to worry about eucrisa this summer. Someone forgot to order ingredients to make it. Now we have a “shortage”. You can’t make this up. The “sorority girls” step in it again.
 




anonymous said:
Guess we won’t have to worry about eucrisa this summer. Someone forgot to order ingredients to make it. Now we have a “shortage”. You can’t make this up. The “sorority girls” step in it again.
Click to expand...

Does anyone write it anyway? It's awful.

What's the salary range for these positions and target bonus please? I'm interviewing now. Thanks
 
























Top Bottom
Back
Quote